Antiarrhythmic effects of tiapamil and propranolol assessed from the reduction of ventricular arrhythmias in the cycloergometer test. A double-blind study.
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D005117:Cardiac Complexes, Premature / Q000188:drug therapy / Q000503:physiopathology*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005080:Exercise Test; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000494:pharmacology*; D011437:Propylamines / Q000494:pharmacology*; D013976:Tiapamil Hydrochloride
D000889:Anti-Arrhythmia Agents; D011437:Propylamines; D011433:Propranolol; D013976:Tiapamil Hydrochloride